FDA 执法报告 D-0173-2027 将 American Health Packaging 氰钴胺注射液 24394A 批次列为二级召回
FDA drug enforcement D-0173-2027: American Health Packaging — Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.
FDA 召回执法报告 D-0173-2027 将 American Health Packaging 的氰钴胺注射液 1,000 mcg/mL 批次 24394A 列为二级召回,原因为潜在玻璃颗粒污染。该召回由企业自愿发起,发起日期为 2026 年 10 月 22 日,涉及 4,097 箱、全美分销。报告日期为 2026 年 11 月 11 日,状态 Ongoing 不代表实时召回进展。
记录载明该注射剂批次因潜在玻璃颗粒污染被列为二级召回,并给出批号与全美分销范围,便于核对召回边界。
FDA 药品召回执法报告 — D-0173-2027
报告发布日期:2026-11-11。这是执法报告日期,不是召回启动日期。
范围:一条已分类的药品召回记录;event_id 可能归组多个产品。无召回编号的未分类记录不在本数据流范围内。本记录不是新闻稿,也不是新的执法认定。
openFDA 数据集每周更新。报告状态不是实时召回状态,不得用于跟踪召回生命周期。以下其他日期保留其各自名称所对应的含义。
完整官方产品记录(包括 openFDA 统一标识符):
{
"address_1": "2550 John Glenn Ave Ste A",
"address_2": "",
"center_classification_date": "20261105",
"city": "Columbus",
"classification": "Class II",
"code_info": "Lot: 24394A, Exp 10-31-2026",
"country": "United States",
"distribution_pattern": "Nationwide in the USA",
"event_id": "100204",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {},
"postal_code": "43217-1188",
"product_description": "Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint Laboratories. Carton NDC 68001-542-60; Vial NDC 68001-542-59",
"product_quantity": "4,097- cartons (25 x 1mL vials)",
"product_type": "Drugs",
"reason_for_recall": "Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.",
"recall_initiation_date": "20261022",
"recall_number": "D-0173-2027",
"recalling_firm": "American Health Packaging",
"report_date": "20261111",
"state": "OH",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov